Uncategorized

Transaction Case Studies SELL-SIDE ENGAGEMENT LEADING TO A REVERSE MERGER BETWEEN BIOPHARMX AND TIMBER PHARMACEUTICALS Situation Assessment A wholly-owned subsidiary […]

Transaction Case Studies MULTI-TRACK ENGAGEMENT LEADING TO $30M EQUITY RAISE Situation Assessment Regenacy was spun-out from Acetylon Pharmaceuticals in connection with Celgene’s acquisition

Transaction Case Studies Chinese Joint Venture to Facilitate Indication Expansion Opportunity Situation Assessment Regenacy was spun-out from Acetylon Pharmaceuticals in

Transaction Case Studies MANA THERAPEUTICS: ROBUST DUAL-TRACK PROCESS TO A SUCCESSFUL $35M SERIES A FINANCING Situation Assessment Mana Therapeutics is

Transaction Case Studies SELL-SIDE ENGAGEMENT FOR GRITSTONE LEADING TO A PARTNERSHIP WITH GILEAD FOR $60M UPFRONT AND $725M IN ADDITIONAL

Transaction Case Studies RAPID FINANCING PROCESS LED TO OVERSUBSCRIBED CROSSOVER FINANCING Situation Assessment C4 Therapeutics is a private biotech with

Transaction Case Studies IPO Advisory assignment helping raise $210M in a NASDAQ IPO Situation Assessment Following the completion of a

Transaction Case Studies SUCCESSFUL CHINA SELL-SIDE LICENSING PROCESS FOR A TREATMENT FOR PEDIATRIC MYOPIA Situation Assessment Nevakar is a private

Transaction Case Studies JAPAN COLLABORATION FOR A PHASE 2 ORPHAN DERMATOLOGY ASSET AC-203, A NOVEL TOPICAL TREATMENT FOR EPIDERMOLYSIS BULLOSA

Podcast: Play in new window | Download (Duration: 11:03 — 25.3MB)

Subscribe: Apple Podcasts | Spotify | RSS

During this episode of Biotalk, Geoff Meyerson, CEO of Locust Walk, unpacks our 2024 Q1 Report: Global Trends in Biopharma Transactions Report. Each quarter,